 |
 |
PHARMA FIRM MERCK SLASHES JOBS IN SWITZERLAND
The struggling German pharmaceuticals group Merck KGaA said Tuesday it would close the headquarters of a subsidiary in Geneva, cutting 580 Swiss jobs ...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
1 month ago
|
 |
DOW'S NEW CORN - "TIME BOMB" OR FARMERS' DREAM?
(Reuters) - A new biotech corn developed by Dow AgroSciences could answer the prayers of U.S. farmers plagued by a fierce epidemic of super-weeds. Or ...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
1 month ago
|
 |
ASTRA SAYS LOOKS AT "EVERYTHING", SILENT ON AMYLIN
LONDON (Reuters) - AstraZeneca , which plans to buy Ardea Biosciences for $1.26 billion (782.8 million pounds), is also looking at a range of other bi...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
1 month ago
|
 |
ASTRA FUELS BIOTECH M&A WITH $1.26 BILLION ARDEA BUY
LONDON (Reuters) - AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion (782.31 million pounds), giving it a new gout drug t...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
1 month ago
|
 |
PETER THIEL'S BREAKOUT LABS AWARDS $350K EACH TO SIX AMBITIOUS BIOTECH STARTUPS
While most of us are still reeling in shock last week's one billion Instagram buy, Peter Thiel -- through both Founders Fund and the Thiel ...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
1 month ago
|
 |
GSK UPS LUNG DRUG BET BY BUYING MORE OF THERAVANCE
LONDON (Reuters) - GlaxoSmithKline bet another $212.9 million on the success of lung drug Relovair on Monday by raising its stake in U.S. biotech firm...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
2 months ago
|
 |
AMGEN, ASTRA TO COLLABORATE ON SEVERAL DRUGS
(Reuters) - Amgen Inc and British drugmaker AstraZeneca Plc announced on Monday a major collaboration deal to jointly develop and sell five biotech dr...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
2 months ago
|
 |
GENMAB SAYS GSK SETTLES PATENT CASE WITH GENENTECH
COPENHAGEN (Reuters) - Danish biotech company Genmab said on Tuesday its partner GlaxoSmithKline had agreed a settlement with Roche-owned Genentech re...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
2 months ago
|
 |
MONTHLY SHOT LOWERS CHOLESTEROL 66 PERCENT: STUDY
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a s...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
2 months ago
|
 |
GSK CONFIRMS $800 MILLION UK MANUFACTURING INVESTMENT
LONDON (Reuters) - GlaxoSmithKline , Britain's biggest drugmaker, confirmed plans on Thursday to invest more than 500 million pounds ($792 millio...[ BIOTECH ARTICLES, ANALYSIS]
|
 |
|
2 months ago
|
 |
|
( Page 1 of 6 ) 2 3 4 5 6 |